Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Polygenic determinants of Parkinson's disease in a Chinese population.

Guo JF, Li K, Yu RL, Sun QY, Wang L, Yao LY, Hu YC, Lv ZY, Luo LZ, Shen L, Jiang H, Yan XX, Pan Q, Xia K, Tang BS.

Neurobiol Aging. 2015 Jan 6. pii: S0197-4580(14)00847-1. doi: 10.1016/j.neurobiolaging.2014.12.030. [Epub ahead of print]

PMID:
25623333
2.

Genomic and pharmacogenomic biomarkers of Parkinson's disease.

Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Martin E, Agundez JA.

Curr Drug Metab. 2014 Feb;15(2):129-81. Review.

PMID:
24694231
3.

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

Dan X, Wang C, Ma J, Feng X, Wang T, Zheng Z, Chan P.

Neurobiol Aging. 2014 Jul;35(7):1780.e7-1780.e10. doi: 10.1016/j.neurobiolaging.2014.01.025. Epub 2014 Jan 25.

PMID:
24559644
4.

Identification of a novel Parkinson's disease locus via stratified genome-wide association study.

Hill-Burns EM, Wissemann WT, Hamza TH, Factor SA, Zabetian CP, Payami H.

BMC Genomics. 2014 Feb 10;15:118. doi: 10.1186/1471-2164-15-118.

5.

Pathway analysis of genome-wide association studies for Parkinson's disease.

Song GG, Lee YH.

Mol Biol Rep. 2013 Mar;40(3):2599-607. doi: 10.1007/s11033-012-2346-9. Epub 2012 Dec 13.

PMID:
23238920
6.

Evaluation of Parkinson disease risk variants as expression-QTLs.

Latourelle JC, Dumitriu A, Hadzi TC, Beach TG, Myers RH.

PLoS One. 2012;7(10):e46199. doi: 10.1371/journal.pone.0046199. Epub 2012 Oct 5.

7.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

8.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium.

Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.

9.

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.

Trotta L, Guella I, Soldà G, Sironi F, Tesei S, Canesi M, Pezzoli G, Goldwurm S, Duga S, Asselta R.

Parkinsonism Relat Disord. 2012 Mar;18(3):257-62. doi: 10.1016/j.parkreldis.2011.10.014. Epub 2011 Nov 21.

10.

The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.

Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Giladi N, Orr-Urtreger A.

J Mol Neurosci. 2012 Mar;46(3):541-4. doi: 10.1007/s12031-011-9641-0. Epub 2011 Sep 6.

PMID:
21898123
11.

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Biernacka JM, Armasu SM, Cunningham JM, Ahlskog JE, Chung SJ, Maraganore DM.

Parkinsonism Relat Disord. 2011 Dec;17(10):730-6. doi: 10.1016/j.parkreldis.2011.07.001. Epub 2011 Aug 3.

PMID:
21816655
12.

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.

Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, Lee JH.

BMC Med Genet. 2011 Aug 3;12:104. doi: 10.1186/1471-2350-12-104.

13.

[Analysis of single nucleotide polymorphism rs415430 in the WNT3 gene in the Russian population with the Parkinson disease].

Filatova EV, Shadrina MI, Fedotova EIu, Slominskiĭ PA, Illarioshkin SN, Ivanova-Smolenskaia IA, Limborskaia SA.

Mol Gen Mikrobiol Virusol. 2011;(2):3-4. Russian.

PMID:
21789800
14.

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.

Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N.

PLoS Genet. 2011 Jun;7(6):e1002141. doi: 10.1371/journal.pgen.1002141. Epub 2011 Jun 23.

15.

Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.

Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H.

Mov Disord. 2011 Oct;26(12):2190-5. doi: 10.1002/mds.23806. Epub 2011 Jun 28.

16.

Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.

Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, Ribacoba R, Lorenzo-Betancor O, Samaranch L, Pastor P, Cervantes S, Infante J, Garcia-Gorostiaga I, Sierra M, Combarros O, Snapinn KW, Edwards KL, Zabetian CP.

Mov Disord. 2011 Apr;26(5):819-23. doi: 10.1002/mds.23642. Epub 2011 Mar 21.

17.

Common variants in PARK loci and related genes and Parkinson's disease.

Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Lincoln SJ, Ortolaza AI, Farrer MJ, Cunningham JM, Rocca WA, Maraganore DM.

Mov Disord. 2011 Feb 1;26(2):280-8. doi: 10.1002/mds.23376. Epub 2010 Dec 13.

18.

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

Setó-Salvia N, Clarimón J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O, Mateo JI, Regaña D, Martínez-Corral M, Marquié M, Alcolea D, Suárez-Calvet M, Molina-Porcel L, Dols O, Gómez-Isla T, Blesa R, Lleó A, Kulisevsky J.

Arch Neurol. 2011 Mar;68(3):359-64. doi: 10.1001/archneurol.2011.17.

PMID:
21403021
19.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Krüger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilariño-Güell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Ann Neurol. 2011 May;69(5):778-92. doi: 10.1002/ana.22321. Epub 2011 Mar 9.

20.

Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.

Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, Tekin D, Martin ER, Jiang Z, Mash DC, ffrench-Mullen J, Pericak-Vance MA, Tsinoremas N, Vance JM.

PLoS One. 2011 Feb 22;6(2):e16917. doi: 10.1371/journal.pone.0016917.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk